Nexalin Technology (NXL) Operating Expenses (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Operating Expenses of $2.1 million in Q1 2026, down 16.81% quarter-over-quarter from $2.6 million in Q4 2025, and up 4.63% on a YoY basis from $2.0 million in Q1 2025.
Nexalin Technology (NXL) Operating Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology's Operating Expenses history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 4.63% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $8.7 million (down 0.65% YoY), while the FY2025 annual figure was $8.6 million, up 9.44% from the prior year.
- Operating Expenses was $2.1 million for Q1 2026 at Nexalin Technology, down from $2.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $2.9 million in Q4 2024 to a low of $651219.0 in Q3 2022.
- Historically, Operating Expenses has averaged $1.6 million across 5 years, with a median of $1.6 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses tumbled 64.65% in 2022, then soared 274.02% in 2023.
- A 5-year view of Operating Expenses shows it stood at $751174.0 in 2022, then surged by 118.3% to $1.6 million in 2023, then soared by 76.55% to $2.9 million in 2024, then dropped by 11.43% to $2.6 million in 2025, then slipped by 16.81% to $2.1 million in 2026.
- The last three Operating Expenses figures came in at $2.1 million (Q1 2026), $2.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 3.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 822.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -668.50 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 495.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 380.30 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 2.56 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 903,026.00 |
| Mar 31, 2023 | 802,876.00 |
| Dec 31, 2022 | 751,174.00 |
| Sep 30, 2022 | 651,219.00 |
| Jun 30, 2022 | 736,359.00 |
| Mar 31, 2022 | 652,424.00 |
| Dec 31, 2021 | 602,494.00 |
| Sep 30, 2021 | 1.84 Mn |